Tower Research Capital LLC (Trc) Yumanity Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.99 $2,093 - $4,083	-2,052 Reduced 45.56%	2,452 $4,000
Q1 2022 May 12, 2022	BUY	$0.97 - $3.27 $4,020 - $13,554	4,145 Added 1154.6%	4,504 $7,000
Q4 2021 Feb 14, 2022	BUY	$2.81 - $10.48 $1,008 - $3,762	359 New	359 $1,000
Q3 2021 Nov 15, 2021	SELL	$8.3 - $12.04 $5,909 - $8,572	-712 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$11.27 - $19.64 $8,024 - $13,983	712 New	712 $8,000

Q1 2021 May 17, 2021	SELL	$16.69 - $22.52 $83 - $112	-5 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.67 - $25.4 $83 - $127	5 New	5 $0

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.